 |
|
|
| |
Metabolics, Comorbidities & Aging at IAS 2021
|
| |
| |
IAS: Changes in Inflammation Scores Among People Living
with HIV (PLWH) Under Different Antiretroviral Treatment (ART) Regimes - (08/23/21)
IAS:
Baricitinib reduces macrophage-mediated inflammation in HIV infection - (08/23/21)
IAS:
Ageing and renal insufficiency in persons living with and without HIV in AFRICOS - (08/23/21)
IAS:
Daily Variations- HIV & Immunity, T-Cell Exhaustion in Vertically Acquired HIV-children/adolescents/adults - (08/23/21)
IAS: Sexual Minority Stress and Accelerated Cellular aging in Treated HIV Infection - (08/06/21)
IAS: PSYCHOLOGICAL STRESS IS ASSOCIATED WITH CAROTID
INFLAMMATION IN PERSONS WITH TREATED HIV INFECTION - (08/13/21)
Immunoscenescence and HIV: mutual interactions? - (07/26/21)
Higher comorbidity and comedication burden in women and young people living with HIV More Comorbidities, Polypharmacy With HIV-But Subgroup Differences Abound - (07/21/21)....comorbidity rates steeply increase with aging; HIV+ women & African-Americans show higher rates of comorbidities, as well younger PLWH show higher rates of comorbidities compared to HIV-unifected
Immunoscenescence and HIV: mutual interactions? - (07/26/21)
Aging PLWH & Higher Readmission Hospital Rates than the General Population Hospital Readmissions Fall in Big HIV Group But Still High vs Non-HIV Patients - (07/23/21)
The association of cardiovascular risk factors and disease in people living with HIV in the UK: a retrospective matched cohort study - (07/21/21)
The association of cardiovascular risk factors and disease in people living with HIV in the UK: a retrospective matched cohort study Higher CVD Risk With HIV, Especially in People Younger Than 40 - Mark Mascolini - (07/21/21).....we found an increased risk for CVD despite controlling for common risk factors which included age, sex, ethnicity, deprivation, BMI, smoking status and comorbidities at baseline including hypertension, type 1 and 2 diabetes, lipid-lowering drug use and chronic kidney disease. The second point can be taken from our sub-group analysis where we see that irrespective of age, sex and smoking status, people with HIV have a heightened risk of CVD.....typical assessment tools rely on these characteristics to determine CVD risk, but given our analysis, it is likely these tools do not accurately detect CVD risk in people living with HIV
Poor sleep quality in people with HIV linked to lower CSF amyloid beta 42 - (07/26/21)
Integrase strand transfer inhibitor (INSTI) use and cancer incidence - (07/23/21)
Safety Analysis of Islatravir in Combination With Doravirine in Treatment-Naïve Adults With HIV-1 Infection Through 96 Weeks Islatravir/Doravirine Adverse Events Less Frequent in Second Half of 96-Week Trial - Mark Mascolini (07/22/21)
Long-term Analysis of B/F/TAF in Treatment-Naïve Adults Living With HIV Through Four Years of Follow-up - (07/21/21)
METABOLIC HEALTH OUTCOMES AT WEEK 144 IN THE TANGO STUDY, COMPARING A SWITCH TO DTG/3TC VERSUS MAINTENANCE OF TAF-BASED REGIMENS - (07/20/21)
Week 72 Outcomes and COVID-19 Impact From the BRAAVE 2020 Study: A Randomized Switch to B/F/TAF in Black American Adults With HIV - (07/20/21)
Week 96 Metabolic and Bone Outcomes of a Phase 2b Trial of Islatravir and Doravirine - (07/19/21)
Switching to bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) in adults aged 65 years or older: week 96 results from an international, Phase 3b, open-label trial - (07/19/21)
The safety and efficacy of maintenance with doravirine/lamivudine/tenofovir through 192 weeks in adults with HIV-1: Results from the DRIVE-AHEAD clinical trial - (07/19/21)
SWITCHING TO THE 2-DRUG REGIMEN OF DOLUTEGRAVIR/LAMIVUDINE (DTG/3TC) FIXED-DOSE COMBINATION IS NON-INFERIOR TO CONTINUING A 3-DRUG REGIMEN THROUGH 48 WEEKS IN A RANDOMIZED CLINICAL TRIAL (SALSA) - (07/20/21)
IAS: Switch to INSTI more than offset negative effects of weight gain on incidence of insulin resistance in people living with HIV - (08/09/21)
IAS: Combination of high liver and visceral fat predict diabetes in people living with HIV - (08/09/21)
IAS: The association of coronary calcification with visceral adiposity in people living with HIV. Results from the Liverpool multiparametric imaging collaboration - (08/06/21)
IAS: Sexual Minority Stress and Accelerated Cellular aging in Treated HIV Infection - (08/06/21)
IAS: Prevalence and predictors of elevated arterial blood pressure in ageing people living with HIV attending care in Zambia - (08/06/21)
|
| |
|
|
|
|
|
